Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

ANIX

Anixa Biosciences Inc

May 06 • 04:00PM ET

3.06

+0.06 2.00 %

Healthcare • Biotechnology • USA • Micro • NASD

Peers: FATE AFMD INO BGMS ARQT MRKR ADAP KPTI MDGL BNTC

| Held by: VTI VXF IWC

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.32	Insider Own	5.38%	Shs Outstand	33.46M	Perf Week	6.25%
Market Cap	102.59M	Forward P/E	-	EPS next Y	-0.31	Insider Trans	0.56%	Shs Float	31.72M	Perf Month	13.75%
Enterprise Value	87.35M	PEG	-	EPS next Q	-0.08	Inst Own	16.94%	Short Float	3.29%	Perf Quarter	4.79%
Income	-10.31M	P/S	-	EPS this Y	5.03%	Inst Trans	1.23%	Short Ratio	8.86	Perf Half Y	-26.09%
Sales	0.00M	P/B	6.79	EPS next Y	2.87%	ROA	-60.39%	Short Interest	1.04M	Perf YTD	-1.92%
Book/sh	0.45	P/C	7.22	EPS next 5Y	0.55%	ROE	-62.61%	52W High	5.46 -43.92%	Perf Year	16.35%
Cash/sh	0.42	P/FCF	-	EPS past 3/5Y	9.05% 5.67%	ROIC	-67.69%	52W Low	2.44 25.41%	Perf 3Y	-21.74%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	6.69% 5.85%	Perf 5Y	-28.34%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	19.02%	Oper. Margin	-	ATR (14)	0.18	Perf 10Y	5.89%
Dividend Ex-Date	-	Quick Ratio	12.18	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	55.81	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	12.18	EPS Q/Q	21.94%	SMA20	3.62%	Beta	0.65	Target Price	10.00
Payout	-	Debt/Eq	0.01	Sales Q/Q	-	SMA50	7.38%	Rel Volume	0.86	Prev Close	3.00
Employees	4	LT Debt/Eq	0.01	Earnings	Mar 13	SMA200	-8.95%	Avg Volume	117.66K	Price	3.06
IPO	Oct 07, 1983	Option/Short	Yes / Yes	EPS/Sales Surpr.	7.86% -	Trades		Volume	100,824	Change	2.00%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)